nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—Sensitisation—Alitretinoin—peripheral nervous system neoplasm	0.0118	0.0118	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Tretinoin—peripheral nervous system neoplasm	0.00937	0.00937	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Isotretinoin—peripheral nervous system neoplasm	0.00937	0.00937	CcSEcCtD
Methyl aminolevulinate—Keratitis—Tretinoin—peripheral nervous system neoplasm	0.00859	0.00859	CcSEcCtD
Methyl aminolevulinate—Keratitis—Isotretinoin—peripheral nervous system neoplasm	0.00859	0.00859	CcSEcCtD
Methyl aminolevulinate—Blister—Isotretinoin—peripheral nervous system neoplasm	0.00773	0.00773	CcSEcCtD
Methyl aminolevulinate—Blister—Tretinoin—peripheral nervous system neoplasm	0.00773	0.00773	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Tretinoin—peripheral nervous system neoplasm	0.00716	0.00716	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Isotretinoin—peripheral nervous system neoplasm	0.00716	0.00716	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Alitretinoin—peripheral nervous system neoplasm	0.0071	0.0071	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Melphalan—peripheral nervous system neoplasm	0.00707	0.00707	CcSEcCtD
Methyl aminolevulinate—Rash pustular—Tretinoin—peripheral nervous system neoplasm	0.00699	0.00699	CcSEcCtD
Methyl aminolevulinate—Rash pustular—Isotretinoin—peripheral nervous system neoplasm	0.00699	0.00699	CcSEcCtD
Methyl aminolevulinate—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.00688	0.00688	CcSEcCtD
Methyl aminolevulinate—Stinging—Tretinoin—peripheral nervous system neoplasm	0.00688	0.00688	CcSEcCtD
Methyl aminolevulinate—Eye irritation—Tretinoin—peripheral nervous system neoplasm	0.00653	0.00653	CcSEcCtD
Methyl aminolevulinate—Eye irritation—Isotretinoin—peripheral nervous system neoplasm	0.00653	0.00653	CcSEcCtD
Methyl aminolevulinate—Keratitis—Alitretinoin—peripheral nervous system neoplasm	0.00651	0.00651	CcSEcCtD
Methyl aminolevulinate—Ulcer—Tretinoin—peripheral nervous system neoplasm	0.00589	0.00589	CcSEcCtD
Methyl aminolevulinate—Ulcer—Isotretinoin—peripheral nervous system neoplasm	0.00589	0.00589	CcSEcCtD
Methyl aminolevulinate—Blister—Alitretinoin—peripheral nervous system neoplasm	0.00586	0.00586	CcSEcCtD
Methyl aminolevulinate—Ulcer—Melphalan—peripheral nervous system neoplasm	0.00582	0.00582	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Tretinoin—peripheral nervous system neoplasm	0.00551	0.00551	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Isotretinoin—peripheral nervous system neoplasm	0.00551	0.00551	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Alitretinoin—peripheral nervous system neoplasm	0.00542	0.00542	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Tretinoin—peripheral nervous system neoplasm	0.00532	0.00532	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Isotretinoin—peripheral nervous system neoplasm	0.00532	0.00532	CcSEcCtD
Methyl aminolevulinate—Rash pustular—Alitretinoin—peripheral nervous system neoplasm	0.0053	0.0053	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Melphalan—peripheral nervous system neoplasm	0.00525	0.00525	CcSEcCtD
Methyl aminolevulinate—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.00521	0.00521	CcSEcCtD
Methyl aminolevulinate—Sensitisation—Epirubicin—peripheral nervous system neoplasm	0.00517	0.00517	CcSEcCtD
Methyl aminolevulinate—Eye irritation—Alitretinoin—peripheral nervous system neoplasm	0.00495	0.00495	CcSEcCtD
Methyl aminolevulinate—Ulcer—Dactinomycin—peripheral nervous system neoplasm	0.00482	0.00482	CcSEcCtD
Methyl aminolevulinate—Sensitisation—Doxorubicin—peripheral nervous system neoplasm	0.00479	0.00479	CcSEcCtD
Methyl aminolevulinate—Swelling—Tretinoin—peripheral nervous system neoplasm	0.00459	0.00459	CcSEcCtD
Methyl aminolevulinate—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.00459	0.00459	CcSEcCtD
Methyl aminolevulinate—Eczema—Tretinoin—peripheral nervous system neoplasm	0.0045	0.0045	CcSEcCtD
Methyl aminolevulinate—Eczema—Isotretinoin—peripheral nervous system neoplasm	0.0045	0.0045	CcSEcCtD
Methyl aminolevulinate—Ulcer—Alitretinoin—peripheral nervous system neoplasm	0.00446	0.00446	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Topotecan—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Tretinoin—peripheral nervous system neoplasm	0.00423	0.00423	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Isotretinoin—peripheral nervous system neoplasm	0.00423	0.00423	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Alitretinoin—peripheral nervous system neoplasm	0.00417	0.00417	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Alitretinoin—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Methyl aminolevulinate—Face oedema—Isotretinoin—peripheral nervous system neoplasm	0.00391	0.00391	CcSEcCtD
Methyl aminolevulinate—Face oedema—Tretinoin—peripheral nervous system neoplasm	0.00391	0.00391	CcSEcCtD
Methyl aminolevulinate—Ulcer—Cisplatin—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Methyl aminolevulinate—Ulcer—Etoposide—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Methyl aminolevulinate—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00347	0.00347	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Cisplatin—peripheral nervous system neoplasm	0.00344	0.00344	CcSEcCtD
Methyl aminolevulinate—Eczema—Alitretinoin—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Alitretinoin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Etoposide—peripheral nervous system neoplasm	0.00315	0.00315	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Epirubicin—peripheral nervous system neoplasm	0.00311	0.00311	CcSEcCtD
Methyl aminolevulinate—Face oedema—Alitretinoin—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Doxorubicin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Methyl aminolevulinate—Keratitis—Epirubicin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Methyl aminolevulinate—Swelling—Etoposide—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Epirubicin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Methyl aminolevulinate—Keratitis—Doxorubicin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Tretinoin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Isotretinoin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Methyl aminolevulinate—Blister—Epirubicin—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Methyl aminolevulinate—Face oedema—Cisplatin—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Doxorubicin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Methyl aminolevulinate—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Methyl aminolevulinate—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Epirubicin—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Methyl aminolevulinate—Blister—Doxorubicin—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Methyl aminolevulinate—Rash pustular—Epirubicin—peripheral nervous system neoplasm	0.00232	0.00232	CcSEcCtD
Methyl aminolevulinate—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Doxorubicin—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Methyl aminolevulinate—Rash pustular—Doxorubicin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Methyl aminolevulinate—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Methyl aminolevulinate—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Methyl aminolevulinate—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Methyl aminolevulinate—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Methyl aminolevulinate—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Methyl aminolevulinate—Infection—Topotecan—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Methyl aminolevulinate—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Methyl aminolevulinate—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Methyl aminolevulinate—Infection—Tretinoin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Methyl aminolevulinate—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Methyl aminolevulinate—Oedema—Melphalan—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Methyl aminolevulinate—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Methyl aminolevulinate—Infection—Melphalan—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Methyl aminolevulinate—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Methyl aminolevulinate—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Methyl aminolevulinate—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Methyl aminolevulinate—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Methyl aminolevulinate—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Methyl aminolevulinate—Pain—Topotecan—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Methyl aminolevulinate—Pain—Tretinoin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Methyl aminolevulinate—Pain—Isotretinoin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Methyl aminolevulinate—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Methyl aminolevulinate—Pain—Melphalan—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Methyl aminolevulinate—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Methyl aminolevulinate—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Methyl aminolevulinate—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Methyl aminolevulinate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Methyl aminolevulinate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Methyl aminolevulinate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Methyl aminolevulinate—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Methyl aminolevulinate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Methyl aminolevulinate—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Methyl aminolevulinate—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00151	CcSEcCtD
Methyl aminolevulinate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Methyl aminolevulinate—Eczema—Epirubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Methyl aminolevulinate—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00146	0.00146	CcSEcCtD
Methyl aminolevulinate—Oedema—Vincristine—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Methyl aminolevulinate—Infection—Vincristine—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Methyl aminolevulinate—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Methyl aminolevulinate—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Methyl aminolevulinate—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Methyl aminolevulinate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Methyl aminolevulinate—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Methyl aminolevulinate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Methyl aminolevulinate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Methyl aminolevulinate—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Methyl aminolevulinate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Methyl aminolevulinate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Methyl aminolevulinate—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Methyl aminolevulinate—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Methyl aminolevulinate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Methyl aminolevulinate—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Methyl aminolevulinate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Methyl aminolevulinate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Methyl aminolevulinate—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Methyl aminolevulinate—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Methyl aminolevulinate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Methyl aminolevulinate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Methyl aminolevulinate—Infection—Cisplatin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Methyl aminolevulinate—Rash—Topotecan—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Methyl aminolevulinate—Headache—Topotecan—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Methyl aminolevulinate—Rash—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methyl aminolevulinate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methyl aminolevulinate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methyl aminolevulinate—Headache—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methyl aminolevulinate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methyl aminolevulinate—Pain—Vincristine—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Methyl aminolevulinate—Rash—Melphalan—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Methyl aminolevulinate—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Methyl aminolevulinate—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Methyl aminolevulinate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Methyl aminolevulinate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Methyl aminolevulinate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Methyl aminolevulinate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Methyl aminolevulinate—Infection—Etoposide—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Methyl aminolevulinate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Methyl aminolevulinate—Nausea—Melphalan—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Methyl aminolevulinate—Pain—Cisplatin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Methyl aminolevulinate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Methyl aminolevulinate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Methyl aminolevulinate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Methyl aminolevulinate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Methyl aminolevulinate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Methyl aminolevulinate—Pain—Etoposide—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Methyl aminolevulinate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000996	0.000996	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000979	0.000979	CcSEcCtD
Methyl aminolevulinate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000965	0.000965	CcSEcCtD
Methyl aminolevulinate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00096	0.00096	CcSEcCtD
Methyl aminolevulinate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00095	0.00095	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000949	0.000949	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000946	0.000946	CcSEcCtD
Methyl aminolevulinate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000944	0.000944	CcSEcCtD
Methyl aminolevulinate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000934	0.000934	CcSEcCtD
Methyl aminolevulinate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000921	0.000921	CcSEcCtD
Methyl aminolevulinate—Rash—Vincristine—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Methyl aminolevulinate—Headache—Vincristine—peripheral nervous system neoplasm	0.00091	0.00091	CcSEcCtD
Methyl aminolevulinate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000895	0.000895	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000867	0.000867	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000867	0.000867	CcSEcCtD
Methyl aminolevulinate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000862	0.000862	CcSEcCtD
Methyl aminolevulinate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000844	0.000844	CcSEcCtD
Methyl aminolevulinate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000832	0.000832	CcSEcCtD
Methyl aminolevulinate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000809	0.000809	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000809	0.000809	CcSEcCtD
Methyl aminolevulinate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000808	0.000808	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000802	0.000802	CcSEcCtD
Methyl aminolevulinate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000778	0.000778	CcSEcCtD
Methyl aminolevulinate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000763	0.000763	CcSEcCtD
Methyl aminolevulinate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000747	0.000747	CcSEcCtD
Methyl aminolevulinate—Rash—Etoposide—peripheral nervous system neoplasm	0.000742	0.000742	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000741	0.000741	CcSEcCtD
Methyl aminolevulinate—Headache—Etoposide—peripheral nervous system neoplasm	0.000737	0.000737	CcSEcCtD
Methyl aminolevulinate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000699	0.000699	CcSEcCtD
Methyl aminolevulinate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Methyl aminolevulinate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000659	0.000659	CcSEcCtD
Methyl aminolevulinate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000655	0.000655	CcSEcCtD
Methyl aminolevulinate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.000629	CcSEcCtD
Methyl aminolevulinate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.00061	CcSEcCtD
Methyl aminolevulinate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000606	0.000606	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000592	0.000592	CcSEcCtD
Methyl aminolevulinate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000568	CcSEcCtD
Methyl aminolevulinate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000564	0.000564	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.000548	CcSEcCtD
Methyl aminolevulinate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.000526	CcSEcCtD
Methyl aminolevulinate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Methyl aminolevulinate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000486	0.000486	CcSEcCtD
Methyl aminolevulinate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000485	CcSEcCtD
Methyl aminolevulinate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000473	0.000473	CcSEcCtD
Methyl aminolevulinate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Methyl aminolevulinate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000438	CcSEcCtD
Methyl aminolevulinate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Methyl aminolevulinate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Methyl aminolevulinate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000416	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Methyl aminolevulinate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Methyl aminolevulinate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Methyl aminolevulinate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Methyl aminolevulinate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000385	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000384	CcSEcCtD
Methyl aminolevulinate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Methyl aminolevulinate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000362	CcSEcCtD
